Showing articles with keyword: Purdue | CLEAR
May 14, 2018
Training Opportunity: New Tool for Understanding ‘Omics Data
The Indiana CTSI has made available a shared license for QIAGEN’s Ingenuity Pathway Analysis (IPA), a powerful analysis and search tool that uncovers the significance of ‘omics data and identifies new targets or candidate biomarkers within the context of biological systems. With its many features, IPA allows you to quickly understand and visualize your data.
IU, Purdue and Notre Dame researchers can purchase sub-licenses to use this product. The new licensing period is from July 1, 2018, to June 30, 2019.
If you’re interested in learning more, please join us at one of the free IPA training workshops listed below. These hands-on sessions...
April 26, 2018
CTSI-Supported Researchers Identify ‘Key’ Molecule in Parkinson’s Disease
By Steve Tally:
A molecule has been identified that appears to play an important role in the development of Parkinson’s disease, a debilitating disease that affects millions of people around the world.
A key factor in the development of Parkinson’s disease has been identified by a team of researchers at Purdue University. Jean-Christophe (Chris) Rochet, professor in the Department of Medicinal Chemistry and Molecular Pharmacology in the College of Pharmacy (left) and Dr. Riyi Shi, professor in the Department of Basic Medical Sciences, College of Veterinary Medicine and Weldon School of Biomedical Engineering. (Purdue University photo by Alex Kumar)
The discovery could lead...